Synthetic Biology Firm Triton Algae Raises $5M in Series A Round | GenomeWeb

NEW YORK (GenomeWeb News) – Synthetic biology technology firm Triton Algae today announced it raised $5 million in a Series A equity financing round.

The investment made by Heliae Technology Holdings will go toward ongoing R&D at San Diego-based Triton, expansion of its PhycoLogix platform, and commercialization of its first product called PhycoShield.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.